Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
NCT00781547Phase 3Completed
- Sponsor
- University of Gothenburg
- Start
- Jan 1999
- Primary completion
- Sep 2003
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in metabolic syndrome and abdominal obesity comparing Genotropin with Placebo (2 arms). Primary endpoint: Glucose tolerance at 12 months. Started Jan 1999; status: completed.
02
Drugs
somatropin
03
Conditions
metabolic syndromeabdominal obesity
Beyond the preview
Go deeper on NCT00781547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781547.